{"title":"Echocardiographic predictors of right ventricular failure following left ventricular assist device implantation: Systematic review and meta-analysis.","authors":"Shruti Rajendra, Yousuf Salmasi, Espeed Khoshbin","doi":"10.21542/gcsp.2025.35","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong> Right ventricular failure (RVF) is a significant complication following left ventricular assist device (LVAD) implantation, with no universally accepted predictors. This meta-analysis identifies the most reliable echocardiographic predictors.</p><p><strong>Methods: </strong>OVID Medline was systematically searched for observational studies reporting ten preoperative echocardiographic parameters in patients who did and did not develop RVF post-LVAD. Random-effects meta-analyses were performed. Subgroup analyses and meta-regression assessed the influence of RVF definitions and clinical characteristics on predictive capacity. Logistic regression modeling identified key cutoffs.</p><p><strong>Results: </strong>Thirty-nine studies involving 2,975 patients were included, with pooled RVF prevalence of 0.30 (0.26-0.34). Higher right ventricular end-diastolic diameter (RVEDD) (SMD: 0.368, <i>p</i> < 0.0001, I<sup>2</sup>: 1.73%) and less negative right ventricular free wall strain (RVFWS) (SMD: 0.931, <i>p</i> < 0.0001, I<sup>2</sup>: 82.9%) were significant predictors. Higher right ventricular end-diastolic area (RVEDA) was also reliable but weaker (SMD: 0.224, <i>p</i> = 0.0282, I<sup>2</sup>: 0.00%). Lower tricuspid annular plane systolic excursion (TAPSE) was a strong predictor (SMD: -0.512, <i>p</i> < 0.0001,) but less reliable due to high heterogeneity (I<sup>2</sup>: 86.1%). Subgroup analyses of TAPSE by RVF definition showed modestly reduced heterogeneity (43.7%). Predictive capacity was significantly better in more stable patients (i.e., no inotropes/IABP, higher INTERMACS status). Logistic regression identified increased RVF risk at RVEDD ≥41.5 mm (sensitivity: 50.0%, specificity: 83.3%) and RVFWS ≥ -11.3% (sensitivity: 88.9%, specificity: 88.9%). Conclusion: RVEDD ≥ 41.5 mm and RVFWS ≥ -11.3% are the strongest, most reliable predictors of RVF post-LVAD. Variations in RVF endpoint definitions only partially explain the observed heterogeneity, while patient characteristics significantly influence predictive accuracy. Future studies should explore subgroup-specific cutoffs.</p>","PeriodicalId":12669,"journal":{"name":"Global Cardiology Science & Practice","volume":"2025 4","pages":"e202535"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13070235/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Cardiology Science & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21542/gcsp.2025.35","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Right ventricular failure (RVF) is a significant complication following left ventricular assist device (LVAD) implantation, with no universally accepted predictors. This meta-analysis identifies the most reliable echocardiographic predictors.
Methods: OVID Medline was systematically searched for observational studies reporting ten preoperative echocardiographic parameters in patients who did and did not develop RVF post-LVAD. Random-effects meta-analyses were performed. Subgroup analyses and meta-regression assessed the influence of RVF definitions and clinical characteristics on predictive capacity. Logistic regression modeling identified key cutoffs.
Results: Thirty-nine studies involving 2,975 patients were included, with pooled RVF prevalence of 0.30 (0.26-0.34). Higher right ventricular end-diastolic diameter (RVEDD) (SMD: 0.368, p < 0.0001, I2: 1.73%) and less negative right ventricular free wall strain (RVFWS) (SMD: 0.931, p < 0.0001, I2: 82.9%) were significant predictors. Higher right ventricular end-diastolic area (RVEDA) was also reliable but weaker (SMD: 0.224, p = 0.0282, I2: 0.00%). Lower tricuspid annular plane systolic excursion (TAPSE) was a strong predictor (SMD: -0.512, p < 0.0001,) but less reliable due to high heterogeneity (I2: 86.1%). Subgroup analyses of TAPSE by RVF definition showed modestly reduced heterogeneity (43.7%). Predictive capacity was significantly better in more stable patients (i.e., no inotropes/IABP, higher INTERMACS status). Logistic regression identified increased RVF risk at RVEDD ≥41.5 mm (sensitivity: 50.0%, specificity: 83.3%) and RVFWS ≥ -11.3% (sensitivity: 88.9%, specificity: 88.9%). Conclusion: RVEDD ≥ 41.5 mm and RVFWS ≥ -11.3% are the strongest, most reliable predictors of RVF post-LVAD. Variations in RVF endpoint definitions only partially explain the observed heterogeneity, while patient characteristics significantly influence predictive accuracy. Future studies should explore subgroup-specific cutoffs.